Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Reproduction. 2017 May 3;154(1):67–77. doi: 10.1530/REP-17-0039

Figure 5.

Figure 5

Placental IGF2 and fetoplacental growth. Examples of IGF2 immunostaining in (A) Uw/N, (B) Ow/Ob, and (C) negative control. Anti-IGF2 only immunostained the remaining cytotrophoblast (T) and villous vascular endothelial cells (EC). (D) Quantitation showed that placental weight increased as IGF2 increased for Ow/Ob (P<0.001) (open squares) but not Uw/N subjects (closed circles). (E) Birthweight increased as IGF2 increased for Ow/Ob subjects (P=0.002) (open squares) and not Uw/N subjects (closed circles).